Aura Biosciences (AURA) vs SL Science (SLBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aura Biosciences (AURA) has outperformed SL Science (SLBT) over the past year, gaining 6.8% versus a loss of 85.3%. SL Science is the larger company by market cap ($852.4 million vs $674.6 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AURA | SLBT |
|---|---|---|
| Share price | $6.51 | $1.52 |
| Market cap | $674.60M | $852.35M |
| 1-day change | +0.70% | +0.66% |
| YTD return | +19.36% | -85.59% |
| 1-year return | +6.81% | -85.32% |
| EPS (TTM) | $-1.75 | $-0.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.54 | $14.50 |
| 52-week low | $4.73 | $1.42 |
| Distance from 52-week high | -31.78% | -89.52% |
| Analyst consensus | none | — |
| Avg. price target upside | +155.19% | — |
| Average volume | 740.43K | 80.48K |
| Shares outstanding | 103.70M | 560.76M |
| Employees | 113 | 14 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AURA has outperformed SLBT by 92.1 percentage points over the past year.
About Aura Biosciences
AURA stock →Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 113 employees
About SL Science
SLBT stock →SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 14 employees
AURA vs SLBT FAQ
Which is bigger, Aura Biosciences or SL Science?
SL Science (SLBT) is larger, with a market capitalization of $852.35M compared with $674.60M for Aura Biosciences (AURA).
Which stock has performed better over the past year, AURA or SLBT?
AURA returned +6.81% over the past 12 months, compared with -85.32% for SLBT (price return, excluding dividends). Past performance does not predict future results.
Are Aura Biosciences and SL Science in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.